Rutgers Researchers Call for Balanced Approach to E-Cigarette Use

Jul.25.2022
Rutgers experts urge balanced approach to examining latest trends in adult e-cigarette use, citing potential benefits and health concerns.

Researchers from Rutgers University are urging for a balanced approach to reviewing the latest trends in adult electronic cigarette use.


Assistant Professor Julia Chen-Sankey and Lecturer Michelle T of the Department of Health Behavior, Society, and Policy at Rutgers School of Public Health, along with Lecturer Bover-Manderski of the Department of Biostatistics and Epidemiology at Rutgers, suggest that while there are clear health concerns associated with using e-cigarettes, particularly among those who have not previously used tobacco products, there are also potential benefits that should not be overlooked.


Researchers at Rutgers University have published an invited commentary in the Journal of the American Medical Association (JAMA) Network Open, reviewing new data on the trend of electronic cigarette use among American adults. The researchers, Chen-Sankey and Bover-Manderski, are also members of the Rutgers Tobacco Studies Center. They discuss the necessity of public health approaches to achieve a balance between risks and potential of electronic cigarettes in promoting smoking cessation among adults who currently use combustible cigarettes.


This study raises important questions about the use of electronic cigarettes by adults in the United States. What did the study find and what questions does it pose for public health policy?


Chen-Sankey's research paper explores the latest trends in electronic cigarette use among adults in the United States in 2017, 2018, and 2020. One of the key findings is that while the use of e-cigarettes among young adults aged 18 to 20 has decreased from 2018 to 2020, it has increased among other age groups. Additionally, there has been an increase in the frequency of daily e-cigarette use among current users.


Perhaps the most shocking revelation is that the usage of e-cigarettes among those who have never smoked combustible cigarettes has significantly increased. While e-cigarettes may have the potential to aid in smoking cessation, there has also been a decrease in the number of traditional smokers attempting to quit.


Bover-Manderski: How can these contradictory findings be applied to health policies? It is important to strike a balance between new teenage users and older smokers who want to quit.


Question: How do we strike this balance?


Chen-Sankey suggests that certain policy developments and strategies could ensure the public health benefits of using e-cigarettes. For instance, the recent authorization of e-cigarette products in the United States. The Food and Drug Administration (FDA) through its PMTA review could help establish public trust in authorized e-cigarette products.


Bover-Manderski stated that in order to increase the acceptance of traditional smokers using e-cigarettes as a means to quit smoking, public health education and mass media dissemination strategies should focus on promoting the evidence-based results of e-cigarettes harm reduction.


Question: Why do some traditional adult smokers refuse to use e-cigarettes as a method to quit smoking?


Chen-Sankey stated that in the past five years, the appeal of e-cigarette products for traditional smokers interested in quitting has decreased, but they have become more attractive to non-smokers. Several factors can help explain this frustrating pattern.


Firstly, policies aimed at reducing youth use of electronic cigarettes may also decrease interest and use among adult smokers attempting to quit. Additionally, media coverage may be shaping smokers' understanding of e-cigarettes as the amount of reporting on the risks for youth using e-cigarettes outweighs the potential benefits for adult combustible cigarette users.


Bover-Manderski suggests that public health organizations and healthcare professionals may need to shift their focus from the potential benefits of using combustible tobacco products among adults, to the risks associated with young people using e-cigarettes.


Question: One highlight of this study was a significant decrease in the proportion of young people aged 18 to 20 who use e-cigarettes. What explains this decrease?


Chen-Sankey suggests that this discrepancy may be related to the Tobacco Act, which limits the sale of tobacco and nicotine products, including e-cigarettes, to this age group starting in January 2020. Another potential explanation is the national restrictions implemented in February 2020 on certain flavored e-cigarettes, which may have significantly reduced their appeal among young people.


Bover-Manderski stated that it is important to acknowledge the impact of COVID-19-related lockdowns and social distancing requirements, which may restrict opportunities for this demographic to use e-cigarettes in social or group settings.


I'm sorry, but I do not have context or any text to translate to standard journalistic English. Please provide more information.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
The Zhengzhou Tobacco Research Institute of China National Tobacco Corporation has filed a patent application for an end-to-end method to analyze the migration and transformation of chemical compounds in heated tobacco products. Using GC-Orbitrap/MS non-targeted analysis, the method compares tobacco substrate and aerosol samples to distinguish compounds transferred directly from the substrate from those newly formed during heating, while also calculating transfer rates. In an example involving nine heated tobacco products, the patent identified 17 newly formed thermal decomposition compounds and 38 transferred compounds.
Aug.13
JT Plans ¥800 Billion Investment in Heated Tobacco Over Three Years, Betting on Ploom as Second Growth Engine
JT Plans ¥800 Billion Investment in Heated Tobacco Over Three Years, Betting on Ploom as Second Growth Engine
Japan Tobacco Inc. (JT) CEO Takehiko Tsutsui said the company plans to invest about ¥800 billion (approximately US$5.4 billion) in heated tobacco products over three years through 2028, aiming to establish Ploom as a second growth engine after combustible cigarettes. Tsutsui said Ploom AURA helped JT increase its share of Japan’s heated tobacco market to 15.8% in the first quarter of 2026. Ploom products are now available in 29 markets, with Ploom AURA sold in 25 markets including Japan. JT also plans to continue its cigarette business while positioning its food operations, particularly frozen noodle products in North America, as another growth opportunity.
Jul.23
Product | BAT Japan Launches virto Bright Peach Click in Japan, Expanding glo Hilo’s Capsule-Based Flavor Portfolio
Product | BAT Japan Launches virto Bright Peach Click in Japan, Expanding glo Hilo’s Capsule-Based Flavor Portfolio
British American Tobacco Japan (BAT Japan) has introduced virto Bright Peach Click, a new heated tobacco stick designed for the glo Hilo system. The product expands the existing virto consumable lineup with a combination of tobacco, menthol and ripe peach flavors, featuring a capsule mechanism that releases additional fruit flavor when activated. The product launched in Japan on July 27, 2026, through glo official online channels, convenience stores and tobacco retailers.
Aug.03
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Holdings said the U.S. Food and Drug Administration notified the company on June 23, 2026, that 30 PACHA vape SKUs with submitted PMTAs had been tentatively identified for inclusion on a planned public-facing FDA webpage. Under enforcement guidance issued by FDA in May, the webpage is intended to identify certain unauthorized products for which the agency generally does not intend to prioritize enforcement of premarket authorization requirements. Charlie’s disclosed the development alongside second-quarter revenue of $3.8 million, up 116% year over year.
Aug.25
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
2Firsts On-Site | CTIHK Showcases Nicotine Pouches, Heated Tobacco and Chinese Cigars at InterTabac 2026
At InterTabac 2026 in Dortmund, China Tobacco International (HK) Company Limited (CTIHK) is exhibiting across two separate booths in Hall 5 and Hall 4. Products observed by 2Firsts include heated tobacco products, nicotine pouches, Chinese cigars and tobacco leaf. Nicotine pouch products on display include TOOP, Shuangxi and Ashima.
Market
Sep.16